This is a non-core endpoint: only basic statistics are computed.
Lipomatosis, not elsewhere classified, drug-induced
E4_LIPOMATOSIS_ADVERSE
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
1 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
-
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to Lipomatosis, not elsewhere classified, drug-induced based on the number of shared cases.
Broader endpoints:
None
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | - | - | - |
Unadjusted prevalence (%) | - | - | - |
Mean age at first event (years) | - | - | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_LIPOMATOSIS_ADVERSE – Lipomatosis, not elsewhere classified, drug-induced
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Lipomatosis, not elsewhere classified, drug-induced
↥Endpoint not on priority list, no data to show.